← Back to headlines
Grifols Launches Biopharma Division on Wall Street
Spanish pharmaceutical company Grifols is listing its Biopharma division on Wall Street in a strategic move to boost its stock and reduce corporate debt.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
